Search research articles
Contact Us
Filters
Showing results (141-150 of 155) with videos related to
Page
of 16
Sort By:
Toxicology Research
|
May 22, 2018
Effects of mid-respiratory chain inhibition on mitochondrial function <i>in vitro</i> and <i>in vivo</i>
Ashley J Broom, Jeffrey Ambroso, Gino Brunori, et al.
Neuroscience Letters
|
December 7, 2007
SOD1A4V-mediated ALS: absence of a closely linked modifier gene and origination in Asia
W J Broom, D V Johnson, K E Auwarter, et al.
Genes & Nutrition
|
October 14, 2008
Evidence that a polymorphism within the 3'UTR of glutathione peroxidase 4 is functional and is associated with susceptibility to colorectal cancer
G Bermano, V Pagmantidis, N Holloway, et al.
British Journal of Obstetrics and Gynaecology
|
October 1, 1981
Human luteal phase function following oocyte aspiration from the immediately preovular graafian follicle of spontaneous ovular cycles
J F Kerin, T J Broom, M M Ralph, et al.
Frontiers in Oncology
|
October 30, 2018
Derivation of Breast Cancer Cell Lines Under Physiological (5%) Oxygen Concentrations
Euphemia Y Leung, Marjan E Askarian-Amiri, Dean C Singleton, et al.
The Journal of Antibiotics
|
April 1, 1996
Chemistry of pseudomonic acid. Part 16. Aryl and heteroaryl ketone derivatives of monic acid
A Abson, N J Broom, P A Coates, et al.
Clinical Genitourinary Cancer
|
August 29, 2014
Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: a randomized first-line phase II trial
Reuben J Broom, Victoria Hinder, Katrina Sharples, et al.
European Journal of Clinical Nutrition
|
July 30, 2005
Empowering primary care to tackle the obesity epidemic: the Counterweight Programme
M McQuigg, J Brown, J Broom, et al.
Obesity Research & Clinical Practice
|
December 20, 2013
The Counterweight programme: Prevalence of CVD risk factors by body mass index and the impact of 10% weight change
M McQuigg, J E Brown, J Broom, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
July 9, 2008
50bp deletion in the promoter for superoxide dismutase 1 (SOD1) reduces SOD1 expression in vitro and may correlate with increased age of onset of sporadic amyotrophic lateral sclerosis
Wendy J Broom, Matthew Greenway, Ghazaleh Sadri-Vakili, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 155) with videos related to
Sort By:
Page
of 16
Toxicology Research
|
May 22, 2018
Effects of mid-respiratory chain inhibition on mitochondrial function <i>in vitro</i> and <i>in vivo</i>
Ashley J Broom, Jeffrey Ambroso, Gino Brunori, et al.
Neuroscience Letters
|
December 7, 2007
SOD1A4V-mediated ALS: absence of a closely linked modifier gene and origination in Asia
W J Broom, D V Johnson, K E Auwarter, et al.
Genes & Nutrition
|
October 14, 2008
Evidence that a polymorphism within the 3'UTR of glutathione peroxidase 4 is functional and is associated with susceptibility to colorectal cancer
G Bermano, V Pagmantidis, N Holloway, et al.
British Journal of Obstetrics and Gynaecology
|
October 1, 1981
Human luteal phase function following oocyte aspiration from the immediately preovular graafian follicle of spontaneous ovular cycles
J F Kerin, T J Broom, M M Ralph, et al.
Frontiers in Oncology
|
October 30, 2018
Derivation of Breast Cancer Cell Lines Under Physiological (5%) Oxygen Concentrations
Euphemia Y Leung, Marjan E Askarian-Amiri, Dean C Singleton, et al.
The Journal of Antibiotics
|
April 1, 1996
Chemistry of pseudomonic acid. Part 16. Aryl and heteroaryl ketone derivatives of monic acid
A Abson, N J Broom, P A Coates, et al.
Clinical Genitourinary Cancer
|
August 29, 2014
Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: a randomized first-line phase II trial
Reuben J Broom, Victoria Hinder, Katrina Sharples, et al.
European Journal of Clinical Nutrition
|
July 30, 2005
Empowering primary care to tackle the obesity epidemic: the Counterweight Programme
M McQuigg, J Brown, J Broom, et al.
Obesity Research & Clinical Practice
|
December 20, 2013
The Counterweight programme: Prevalence of CVD risk factors by body mass index and the impact of 10% weight change
M McQuigg, J E Brown, J Broom, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
July 9, 2008
50bp deletion in the promoter for superoxide dismutase 1 (SOD1) reduces SOD1 expression in vitro and may correlate with increased age of onset of sporadic amyotrophic lateral sclerosis
Wendy J Broom, Matthew Greenway, Ghazaleh Sadri-Vakili, et al.
Page
of 16